Clinical Trial Update: Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining whether pre-treatment with atorvastatin affects risk during percutaneous coronary intervention in coronary artery diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: University Hospital, Motol | Conditions: Coronary Artery Disease, Coronary Angioplasty | Phase 3 | Status: UNKNOWN